Chiesi, Protalix Receive Positive CHMP Opinion For Pegunigalsidase Alfa To Treat Fabry Disease

RTTNews | 768日前
Chiesi, Protalix Receive Positive CHMP Opinion For Pegunigalsidase Alfa To Treat Fabry Disease

(RTTNews) - Protalix BioTherapeutics, Inc. (PLX) and Chiesi Global Rare Diseases, a business unit of the Chiesi Group, announced Friday that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending marketing authorization for PRX-102 (pegunigalsidase alfa), the first and only pegylated enzyme for the treatment of adult patients with Fabry disease.

PRX-102 is a novel recombinant human a-Galactosidase-A (a-Gal-A) enzyme being investigated as an enzyme replacement therapy (ERT) for the treatment of Fabry disease.

The positive CHMP opinion was based on a marketing authorization application (MAA) that includes positive data from a comprehensive set of preclinical, clinical and manufacturing studies evaluating PRX-102.

The CHMP opinion is now referred for final action to the European Commission (EC). A final EC decision on the MAA is expected in the beginning of May 2023.

read more
Pound Rises Against Majors

Pound Rises Against Majors

The British pound strengthened against other major currencies in the European session on Wednesday.
RTTNews | 4時6分前
Sensex, Nifty Rally As IT, Bank Stocks Rebound

Sensex, Nifty Rally As IT, Bank Stocks Rebound

Indian shares bounced back on Wednesday, after having suffered heavy losses in the previous session amid heightened uncertainty over U.S. President Donald Trump's tariff announcements expected later in the day.
RTTNews | 5時7分前
CAC 40 Modestly Lower In Cautious Trade

CAC 40 Modestly Lower In Cautious Trade

French stocks are down Wednesday morning on a fresh round of selling by investors ahead of U.S. President Donald Trump's "reciprocal tariff" announcement later in the day.
RTTNews | 5時27分前